Clinical, Organisational Factors and COVID-19 Mortality

Clinical, Organisational Factors and COVID-19 Mortality
Coronavirus disease 2019 (COVID-19) is one of the most significant challenges faced by critical care workers worldwide. During the COVID-19 pandemic, an unprecedented number of patients with COVID-19 associated pneumonia were admitted to the ICU. As a result, most healthcare facilities faced capacity issues and had to designate clinical areas to accommodate these patients and provide them with the necessary critical care. Unfortunately, despite the support provided, mortality remains high, particularly in ventilated patients.

In the ESICM UNITE-COVID, a mutlicentre, international, point-prevalence study, the researchers discuss the global burden of COVID-19 admissions and examine the association between clinical and organisational characteristics and outcomes in critically ill COVID-19 patients. The study included 4994 patients from 280 ICUs in 46 countries (Europe 60%, Asia 22%, South America 6%, North America 6%, and Africa 6%) with a confirmed SARS-CoV-2 infection admitted to the ICU between February and May 2020. 

The ICUs included in the study all had to increase their capacity from 4931 beds to 7630 and had to deploy healthcare staff from other areas. The number of patients per ICU nurse increased from 2.0 to 2.4 (during the pandemic surge; the number of intensivists available for clinical care increased from 4.5  to 5.4, and the number of residents providing clinical care increased from 4.3 to 6.2.  Non-ICU nurses and physicians were employed in 85% and 58% of the ICUs, respectively.

One thousand nine hundred eighty-six patients were admitted to surge capacity beds. Invasive ventilation at admission was used in 46.5% of the patients and was required during ICU admission in 85.8% of the patients. 84.7% of the patients were sedated during their stay for a median of 14 days. Vasoactive drugs were used in 75.4% for a median of 8 days, and renal replacement therapy (RRT) was required in 24.3% of the patients. Extracorporeal membrane oxygenation (ECMO) was used in 4.5% of patients for 17 days. 

The 60-day mortality was 33.9%, and the ICU mortality was 32.7%. The primary factors associated with poor patient outcomes were old age, invasive mechanical ventilation and acute kidney injury. The same associations were confirmed in mechanically ventilated patients. The researchers report that admission to surge capacity beds was not associated with mortality. 

Overall, these findings show that while many ICUs had to increase bed availability and staff to manage the patient surge during COVID-19, admission to a surge bed was not associated with increased mortality. 

Image Credit: iStock

«« Nurse Staffing and Mortality Risk of Sepsis

Nutrition Therapy and Clinical Outcomes in Critically Ill Patients »»


Greco M, De Corte T, Ercole A et al. (2022) Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study. Intensive Care Med. 1–16. doi: 10.1007/s00134-022-06705-1. 

Published on : Tue, 31 May 2022

Related Articles

New research presented at Euroanaesthesia 2022 finds that long-term exposure to air pollution is linked to a greater risk of... Read more

Sedation management is a critical component when managing mechanically ventilated patients. It is important to use a protocol-driven... Read more

Findings from the first modelling study to quantify the impact of COVID-19 vaccines show that nearly 19.9 million out of a potential... Read more

mortality, COVID-19, capacity strain Clinical, Organisational Factors and COVID-19 Mortality

No comment

Please login to leave a comment...

Highlighted Products